Home › BRILINTA Receives US FDA Approval For New Administration Option
 

Keywords :   


BRILINTA Receives US FDA Approval For New Administration Option

2015-04-01 08:02:52| drugdiscoveryonline Home Page

AstraZeneca recently announced that the US Food and Drug Administration (FDA) has approved a new administration option for acute coronary syndrome (ACS) patients who are unable to swallow BRILINTA 90 mg tablets whole

Tags: option administration approval receives

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
28.11SCR
28.1146
28.11BOSS OD-2 TURBO Over Drive
28.11/ Pulling the Plug
28.11
28.1110
28.112.5 120
28.11MSV-R
More »